Biotech has long seemed to move slower than its fellow tech fields due to the complexity of biological systems and the difficulty of drug regulations. However, that precedent is set to change thanks to the growing implementation of artificial intelligence (AI), upending the field and bringing big changes to the industry. As a result, the AI-biotech trend will likely determine the winners and losers of the next few decades.
The AI revolution is still in its infancy, so now is the best time to invest in the AI-biotech trend of the future. With that in mind, here are three companies an AI-Biotech investor should look out for.
This post appeared first on InvestorPlace.